Search research articles
Contact Us
Filters
Showing results (91-100 of 115) with videos related to
Page
of 12
Sort By:
The Lancet. Global Health
|
July 15, 2022
Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis
Esther E Freeman, Nicole C McCann, Aggrey Semeere, et al.
Annals of Epidemiology
|
September 23, 2023
Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation study
Parastu Kasaie, Cameron Stewart, Elizabeth Humes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2026
Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi
Mary Feser, Thulani Maphosa, Amir Shroufi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 12, 2025
Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries with the Highest Adult HIV Prevalence
Cameron T Nutt, Richard J Lessells, Winnie R Muyindike, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 18, 2020
Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts
Anne M Neilan, Elena Losina, Audrey C Bangs, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 2, 2026
Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035
Emily P Hyle, Luke Ang, Grace Luu, et al.
Open Forum Infectious Diseases
|
June 24, 2021
Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results
Caitlin M Dugdale, Melis N Anahtar, John J Chiosi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 4, 2020
Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts
Anne M Neilan, Elena Losina, Audrey C Bangs, et al.
JAMA Network Open
|
December 22, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P Baggett, Justine A Scott, Mylinh H Le, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 21, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P Baggett, Justine A Scott, Mylinh H Le, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 115) with videos related to
Sort By:
Page
of 12
The Lancet. Global Health
|
July 15, 2022
Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis
Esther E Freeman, Nicole C McCann, Aggrey Semeere, et al.
Annals of Epidemiology
|
September 23, 2023
Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation study
Parastu Kasaie, Cameron Stewart, Elizabeth Humes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2026
Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi
Mary Feser, Thulani Maphosa, Amir Shroufi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 12, 2025
Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries with the Highest Adult HIV Prevalence
Cameron T Nutt, Richard J Lessells, Winnie R Muyindike, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 18, 2020
Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts
Anne M Neilan, Elena Losina, Audrey C Bangs, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 2, 2026
Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035
Emily P Hyle, Luke Ang, Grace Luu, et al.
Open Forum Infectious Diseases
|
June 24, 2021
Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results
Caitlin M Dugdale, Melis N Anahtar, John J Chiosi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 4, 2020
Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts
Anne M Neilan, Elena Losina, Audrey C Bangs, et al.
JAMA Network Open
|
December 22, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P Baggett, Justine A Scott, Mylinh H Le, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 21, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P Baggett, Justine A Scott, Mylinh H Le, et al.
Page
of 12